197 related articles for article (PubMed ID: 18157944)
1. Isoniazid-rifampicin induced lipid changes in rats.
Pal R; Rana SV; Vaiphei K; Singh K
Clin Chim Acta; 2008 Mar; 389(1-2):55-60. PubMed ID: 18157944
[TBL] [Abstract][Full Text] [Related]
2. The food supplement coenzyme Q10 and suppression of antitubercular drug-induced hepatic injury in rats: the role of antioxidant defence system, anti-inflammatory cytokine IL-10.
Baskaran UL; Sabina EP
Cell Biol Toxicol; 2015 Oct; 31(4-5):211-9. PubMed ID: 26374116
[TBL] [Abstract][Full Text] [Related]
3. Effect of different doses of carotenoids in isoniazid-rifampicin induced hepatotoxicity in rats.
Pal R; Rana S; Vaiphei K; Singh K
Trop Gastroenterol; 2008; 29(3):153-9. PubMed ID: 19115607
[TBL] [Abstract][Full Text] [Related]
4. Reparation of Isoniazid and Rifampicin Combinatorial Therapy-Induced Hepatotoxic Effects by Bacopa monnieri.
Evan Prince S; Udhaya LB; Sunitha PS; Arumugam G
Pharmacology; 2016; 98(1-2):29-34. PubMed ID: 27007136
[TBL] [Abstract][Full Text] [Related]
5. Hepatoprotective effect of Anacyclus pyrethrum Linn. against antitubercular drug-induced hepatotoxicity in SD rats.
Usmani A; Mujahid M; Khushtar M; Siddiqui HH; Rahman MA
J Complement Integr Med; 2016 Sep; 13(3):295-300. PubMed ID: 27101559
[TBL] [Abstract][Full Text] [Related]
6. Effect of different oral doses of isoniazid-rifampicin in rats.
Rana SV; Pal R; Vaiphie K; Singh K
Mol Cell Biochem; 2006 Sep; 289(1-2):39-47. PubMed ID: 16583132
[TBL] [Abstract][Full Text] [Related]
7. Attenuation of anti-tuberculosis therapy induced hepatotoxicity by Spirulina fusiformis, a candidate food supplement.
Martin SJ; Baskaran UL; Vedi M; Sabina EP
Toxicol Mech Methods; 2014 Dec; 24(8):584-92. PubMed ID: 25137345
[TBL] [Abstract][Full Text] [Related]
8. Rifampicin-loaded 'flower-like' polymeric micelles for enhanced oral bioavailability in an extemporaneous liquid fixed-dose combination with isoniazid.
Moretton MA; Hocht C; Taira C; Sosnik A
Nanomedicine (Lond); 2014 Aug; 9(11):1635-50. PubMed ID: 24410279
[TBL] [Abstract][Full Text] [Related]
9. Amelioration of anti-tuberculosis drug induced oxidative stress in kidneys by Spirulina fusiformis in a rat model.
Martin SJ; Sabina EP
Ren Fail; 2016 Aug; 38(7):1115-21. PubMed ID: 27183989
[TBL] [Abstract][Full Text] [Related]
10. Effect of garlic on isoniazid and rifampicin-induced hepatic injury in rats.
Pal R; Vaiphei K; Sikander A; Singh K; Rana SV
World J Gastroenterol; 2006 Jan; 12(4):636-9. PubMed ID: 16489682
[TBL] [Abstract][Full Text] [Related]
11. Monoammonium glycyrrhizinate protects rifampicin- and isoniazid-induced hepatotoxicity via regulating the expression of transporter Mrp2, Ntcp, and Oatp1a4 in liver.
Zhou L; Song Y; Zhao J; Qin H; Zhang G; Zhou Y; Wu X
Pharm Biol; 2016; 54(6):931-7. PubMed ID: 26987268
[TBL] [Abstract][Full Text] [Related]
12. Selected pharmaceutical excipient prevent isoniazid and rifampicin induced hepatotoxicity.
Shih TY; Ho SC; Hsiong CH; Huang TY; Hu OY
Curr Drug Metab; 2013 Jul; 14(6):720-8. PubMed ID: 23701163
[TBL] [Abstract][Full Text] [Related]
13. Role of oxidative stress and nitric oxide in the protective effects of alpha-lipoic acid and aminoguanidine against isoniazid-rifampicin-induced hepatotoxicity in rats.
Saad EI; El-Gowilly SM; Sherhaa MO; Bistawroos AE
Food Chem Toxicol; 2010 Jul; 48(7):1869-75. PubMed ID: 20417245
[TBL] [Abstract][Full Text] [Related]
14. Hepatoprotection by carotenoids in isoniazid-rifampicin induced hepatic injury in rats.
Rana SV; Pal R; Vaiphei K; Ola RP; Singh K
Biochem Cell Biol; 2010 Oct; 88(5):819-34. PubMed ID: 20921993
[TBL] [Abstract][Full Text] [Related]
15. [Anti-tuberculosis chemotherapy and management of adverse reactions].
Kuwabara K
Nihon Rinsho; 2011 Aug; 69(8):1389-93. PubMed ID: 21838035
[TBL] [Abstract][Full Text] [Related]
16. Frequency and tolerance of antituberculosis treatment according to national guidelines for prevention of risk of tuberculosis due to tumor necrosis factor blocker treatment.
Bray MG; Poulain C; Dougados M; Gossec L
Joint Bone Spine; 2010 Mar; 77(2):135-41. PubMed ID: 20097592
[TBL] [Abstract][Full Text] [Related]
17. Effects of repeated administration of rifampicin and isoniazid on vitamin D metabolism in mice.
Sheng L; Xue Y; He X; Zhu Y; Li H; Wu Y; Dang R; Tang M; Jiang P
Steroids; 2015 Dec; 104():203-7. PubMed ID: 26476181
[TBL] [Abstract][Full Text] [Related]
18. Rosa brunonii Lindely fruit as a new protective agent evaluated against Rif/INH induced toxicity in rats.
Ahmad E; Jahangir M; Akhtar ZM; Ishtiaq S; Mukhtar H; Haider HMF; Bukhari NI
Pak J Pharm Sci; 2020 Mar; 33(2(Supplementary)):805-814. PubMed ID: 32863255
[TBL] [Abstract][Full Text] [Related]
19. Encapsulating Rifampicin into SLNs: A Viable Option for Managing its Bioavailability Issues Upon Co-Delivery with Isoniazid.
Singh H; Sood R; Chaira T; Khanna A; Upadhaya DJ; Bambal R; Bhatnagar PK; Singh M; Kaur IP
Curr Drug Deliv; 2020; 17(4):343-347. PubMed ID: 32077827
[TBL] [Abstract][Full Text] [Related]
20. Adverse effects and adherence to treatment of rifampicin 4 months vs isoniazid 6 months for latent tuberculosis: a retrospective analysis.
Fresard I; Bridevaux PO; Rochat T; Janssens JP
Swiss Med Wkly; 2011; 141():w13240. PubMed ID: 21842452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
